About exenatideantidiabetic agent, new class agentmechanism of action of exenatideexenatide is an incretin mimic that acts as an agonist at glucagon-like peptide 1 (glp-1) receptor. it increases glucose-dependent insulin secretion by the pancreatic beta-cells, suppresses inappropriately elevated glucagon secretion, increases beta-cell growth/replication, slows gastric emptying, and decreases food intake.indications for exenatideadjunct to type 2 dminteractions for exenatideparacetamol: reduces the peak plasm level of paracetamol oral hypoglycaemic(sulphonylureas): lead to increase risk of hypoglycaemia warfarin: may enhance anticoagulant effect
المزيد من التفاصيل